The Swiss pharmaceutical giant Roche will pay more than $1 billion in a deal aimed at improving both cancer treatment and drug development. Read it full By ANDREW POLLACK from NYT Business Day http://ift.tt/1yXTvkR
Source: The New York Times
Sunday, January 11, 2015
Roche to Buy Majority Stake in Foundation Medicine, Leader in Tumor Testing
The Swiss pharmaceutical giant Roche will pay more than $1 billion in a deal aimed at improving both cancer treatment and drug development. Read it full By ANDREW POLLACK from NYT Business Day http://ift.tt/1yXTvkR
Source: The New York Times
Latest Posts
-
By Erika Owens You have till Thursday to apply to the JSK fellowships . December 1: WordCamp U.S. Journo Meetup (Philadelphia, PA) De...
-
PROSTATEx Challenge results from academia, industry, government to be presented at SPIE Medical Imaging in February Read Full Story from ...
-
By MOTOKO RICH from NYT Education http://ift.tt/1vyENOd Source: The New York Times http://ift.tt/1vyENOd
-
“If you can, help others; if you cannot do that, at least do not harm them.” - Dalai Lama (via fyp-philosophy ) from Stowe Boyd http://...
-
It’s a postfact world. from Stowe Boyd http://www.stoweboyd.com/post/153786974752
-
Author(s): Henry Farrell Publication Date: June 24, 2015 Publication Type: Other Writing The news that eBay and Amaz...
-
The intended audience of this European Environment Agency (EEA) publication is the professional environmental evaluation community, that is...
-
Purpose: To compare image quality metrics and dose of TrueBeam V2.0’s 2.5MV imaging beam and kV and 6MV images. Methods: To evaluate ...
